USP8 and hepatocellular carcinoma: Consistently, USP8 inhibition by USP8i decreased p-EGFR (~90%), EGFR (~70%), p-c-Met (~50%) and c-Met (~60%) in HCC cells respectively (Figure 5A, 5C).